(2R,3S,6E,11R,14S,15S,17R)-17-(acetyloxy)-6-({[3-(dimethylamino)propyl](methyl)amino}methylidene)-8-hydroxy-3-(methoxymethyl)-2,15-dimethyl-5,9-dioxo-4-oxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1(10),7-dien-14-yl (1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.0⁴,⁹]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl octanedioate | C88H131N3O23 | COC[C@H]1OC(=O)\C(=C\N(C)CCCN(C)C)C2=C(O)C(=O)C3=C([C@@H](C[C@]4(C)[C@H](CC[C@@H]34)OC(=O)CCCCCCC(=O)O[C@@H]3CC[C@@H](C[C@@H](C)[C@@H]4CC(=O)[C@H](C)\C=C(C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(C)\[C@H](C[C@@H]5CC[C@@H](C)[C@@](O)(O5)C(=O)C(=O)N5CCCC[C@H]5C(=O)O4)OC)C[C@H]3OC)OC(C)=O)[C@@]12C | 13671, AE10372, HY-132003

Structure Info

IUPAC Name: (2R,3S,6E,11R,14S,15S,17R)-17-(acetyloxy)-6-({[3-(dimethylamino)propyl](methyl)amino}methylidene)-8-hydroxy-3-(methoxymethyl)-2,15-dimethyl-5,9-dioxo-4-oxatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-1(10),7-dien-14-yl (1R,2R,4S)-4-[(2R)-2-[(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-2,3,10,14,20-pentaoxo-11,36-dioxa-4-azatricyclo[30.3.1.0⁴,⁹]hexatriaconta-16,24,26,28-tetraen-12-yl]propyl]-2-methoxycyclohexyl octanedioate

Supplier	Lead time	Ships from	Purity	Pack	Price, $	Qty
MedChemExpress	30 days	United States To:	90	1 mg	634	Go to cart Enquire
MedChemExpress	30 days	United States To:	90	500 μg	334	Go to cart Enquire
Description: Names: Wortmannin-Rapamycin Conjugate 1; Product Description: Wortmannin-Rapamycin Conjugate 1 (compound 7c) is a furan ring-opened derivative of wortmannin-rapamycin conjugate with potent antitumor activities and a fine water solubility. Wortmannin-Rapamycin Conjugate 1 can inhibit the AKT phosphorylation in the tumor and can be used for cancer research .; Target: Akt; CAS: 1067892-47-0
MedChemExpress EU	30 days	Sweden To:	90	1 mg	668	Go to cart Enquire
MedChemExpress EU	30 days	Sweden To:	90	500 μg	352	Go to cart Enquire
Description: Names: Wortmannin-Rapamycin Conjugate 1; Product Description: Wortmannin-Rapamycin Conjugate 1 (compound 7c) is a furan ring-opened derivative of wortmannin-rapamycin conjugate with potent antitumor activities and a fine water solubility. Wortmannin-Rapamycin Conjugate 1 can inhibit the AKT phosphorylation in the tumor and can be used for cancer research; Target: Akt; CAS: 1067892-47-0

For a custom pack size or bulk
please drop us a line:Enquire